SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (283)12/16/1998 9:21:00 AM
From: Henry Niman  Respond to of 656
 
Today's NY Times has a major article on lack of funding for Biotechs and consolidation of sector. Details linked to Biotech Boom table at biocognizance.com
Last week venture capitalist, Jean Deleage reviewed the sector and sounded some of the same warnings, which are also linked to the table.
IMNX is mentioned



To: Anthony Wong who wrote (283)12/22/1998 10:27:00 PM
From: Buckeye  Read Replies (2) | Respond to of 656
 
Any idea as to the est. of patients using Enbrel for yr. end 99? ML just raised their est. from 33,000 to 50,000 . . . they also raised their yr. 2000 est of revs from 390myn to 670myn . . . what are the bulls on the street looking for . . . ML also described initial Enbrel sales as "off the charts"


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News